Priority areas

  • Targeting adenoviruses to tumors
  • Oncolytic adenoviruses and other oncolytic viruses
  • Gene therapy and oncolytic viruses in combination with other therapeutics
  • Systemic delivery of gene therapy agents
  • Arming oncolytic viruses
  • Immunology of gene therapy
  • Immunotherapy of cancer
  • Using oncolytic viruses to stimulate the adoptive immune system
  • Making T-cell therapies and checkpoint antibodies work in solid tumors
  • Translating preclinical results into clinical trials

In particular, the following diseases are of interest

  • Ovarian cancer
  • Hormone refractory prostate cancer
  • Metastatic breast cancer
  • Lung cancer
  • Metastatic colorectal cancer
  • Pancreatic cancer
  • Gastric cancer
  • Kidney cancer
  • Head and neck cancer